Related content

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Aurora Sheena   Diener Hans-Christoph   Dodick David  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 137-138

Springer Publishing Company

Access to resources Recommend Favorite

Experience with onabotulinumtoxinA (BOTOX) in chronic refractory migraine: focus on severe attacks

By Oterino A.   Ramón C.   Pascual J.  

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 235-238

Springer Publishing Company

Access to resources Recommend Favorite

Topiramate in the Treatment of Chronic Migraine

By Azimova Yu.   Tabeeva G.  

Neuroscience and Behavioral Physiology, Vol. 44, Iss. 3, 2014-03 ,pp. : 310-314

Springer Publishing Company

Access to resources Recommend Favorite

Reading data in migraine acute treatment studies: from clinical trials to reviews and meta-analyses

By Buzzi M.  

The Journal of Headache and Pain, Vol. 7, Iss. 3, 2006-06 ,pp. : 160-164

Springer Publishing Company

Access to resources Recommend Favorite

Understanding Migraine: Advancing from Clinical Trials to Clinical Practice

By Cady Roger K.   Schreiber Curtis P.   Farmer Kathleen U.  

Headache Care, Vol. 1, Iss. 3, 2004-08 ,pp. : 183-190

Informa Healthcare

Access to resources Recommend Favorite